Liquidia Corporation To Present At The 20th Annual Needham Virtual Healthcare Conference
April 07 2021 - 6:00AM
Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Damian
deGoa, Chief Executive Officer of Liquidia, will provide an
overview and update on the company's business during a fireside
chat session at the 20th Annual Needham Virtual Healthcare
Conference.
The presentation will take place on Wednesday,
April 14, 2021, from 1:30 to 2:10 p.m. Eastern Standard Time and
can be accessed via a live webcast on the Liquidia website at
https://liquidia.com/investors/events-and-presentations. An
archived, recorded version of the presentation can be accessed for
90 days following the event.
About Liquidia CorporationLiquidia
Corporation is a biopharmaceutical company focused on the
development and commercialization of products in pulmonary
hypertension and other applications of its PRINT® Technology. The
company operates through its two wholly owned subsidiaries,
Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia
Technologies is developing two product candidates: LIQ861, an
inhaled dry powder formulation of treprostinil for the treatment of
PAH, and LIQ865, an injectable, sustained-release formulation of
bupivacaine for the management of local post-operative pain for
three to five days after a procedure. Liquidia PAH provides the
commercialization for rare disease pharmaceutical products, such as
Treprostinil Injection. Liquidia Corporation is headquartered
in Research Triangle Park, NC. For more information, please
visit www.liquidia.com.
Contact InformationInvestors &
Media:Jason AdairVice President, Corporate Development and
Strategy919.328.4400jason.adair@liquidia.com
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From Apr 2024 to May 2024
Liquidia (NASDAQ:LQDA)
Historical Stock Chart
From May 2023 to May 2024